secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGENUS INC (AGEN)
CIK:        0001098972
Form:       8-K
Filed at:   2025-06-04T23:59:59+00:00
Accession:  0000950170-25-081674
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Agenus sells manufacturing assets to Zydus for $75M upfront; license BOT/BAL in India
--------------------------------------------------------------------------------

- Asset sale of Emeryville/ Berkeley CA facilities for $75M at closing; up to $50M additional contingent payments.
- Exclusive license to Zydus for BOT/BAL in India and Sri Lanka; 5% royalty on net sales.
- Zydus makes $16M equity investment at $7.50/share (approx. 2.1M shares); 12-month lockup.
- Transaction includes contract manufacturing agreement; proceeds to fund BOT/BAL development.
- Parties aim to close within 60 days, subject to customary conditions and government approvals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1098972/000095017025081674/0000950170-25-081674-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1098972/000095017025081674/agen-20250603.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-081674

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer